Recent Posts in Defective Prescription Drugs Category
Active pharmaceutical ingredient (API) manufacturer Zhejiang Huahai Pharmaceuticals was placed on import alert on Friday, September 28 by the U.S. Food and Drug Administration (FDA). The company will determine how its products, used in ...
The U.S. Food and Drug Administration (FDA) recently announced a voluntary recall of drugs that contain valsartan, an active ingredient in a number of products meant to treat heart failure and high blood pressure. While not all products containing ...
People suffering from Helicobacter pylori, a type of stomach bacteria that increases the risk of stomach cancer and ulcers, may still be at risk of stomach cancer even after antibiotic treatment eliminates the bacterium. A new study published by ...
According to a new trial, Invokana has shown an increased risk of leg, foot, and toe amputations. The United States Food and Drug Administration is now releasing an alert to the public regarding the ongoing research involving the use of Invokana ...
As we have noted before, the long-term use of proton pump inhibitors has been linked to an increased risk of serious conditions including heart disease, dementia, and more. Before now, however, researchers were not sure of why this was the case. Now, ...
A recent study links heartburn drugs like Prilosec and Nexium to an increased risk of severe kidney disease. People who take proton pump inhibitors (PPIs) like Prilosec and Nexium for heartburn are 30% more likely to develop chronic kidney disease, ...
According to a new study, the long-term use of various, common heartburn drugs have potential links to an increased risk of kidney disease, damage, and failure. The recent study was conducted and published by the American Society of Nephrology based ...
In May of 2015, the Food and Drug Administration issued warnings regarding the Type 2 diabetes medication Invokana and its link to diabetic ketoacidosis. This condition can be very serious leading to high levels of ketones in the body. There are ...
Attorneys who are representing patients in lawsuits against two big drug markets are claiming that the makers of these drugs withheld important information from a leading medical journal. The companies, Johnson & Johnson and Bayer, are being called ...
Last month, the United States Supreme Court upheld a $124 million trial victory that Bailey Cowan Heckaman PLLC achieved for our client, the State of South Carolina. Janssen Pharmaceuticals attempted to appeal the $124 million judgment, but the ...
In a recent study published in JAMA Internal Medicine, research showed that proton pump inhibitors (PPIs) were linked to chronic kidney disease. These drugs, including those such as Prevacid, Prilosec, and Nexium, have been among the most commonly ...
First approved by the FDA in 1998, Levaquin® is an antibiotic used to treat infections in the body’s organs and skin. In 2004, there was a recognized association between the active ingredient in Levaquin®, levofloxacin, and a type of nerve damage ...
